News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Amol Akhade: Everolimus vs Alpelisib vs Capivasertib
Amol Akhade/LinkedIn
Jun 13, 2024, 03:19

Amol Akhade: Everolimus vs Alpelisib vs Capivasertib

Amol Akhade, Consultant Medical Oncologist atSuyog Cancer Clinics, shared a post on X:

“Everolimus vs Alpelisib vs Capivasertib.

Even though PFS HR are similar for all 3 drugs, only capivasertib has phase III data in patients with cdk4- 6 exposure.

Toxicity profile for capivasertib is better as compared to alpelisib, especially for rash and hyperglycaemia.”

Amol Akhade

Source: Amol Akhade/X

alpelisib Amol Akhade cancer Capivasertib cdk4- 6 exposure everolimus hyperglycaemia OncoDaily Oncology Suyog Cancer Clinics
Special Coverage
Blog
Feb 10, 2025, 18:28
Narjust Florez: Thank you ASCO - never imagined this to happen when still in my 30s
Blog
Feb 10, 2025, 18:24
Stephanie Graff: Thank you, ASCO, for the beautiful award
Science
Feb 10, 2025, 18:20
Leela Morená: Xenotransplantation of a porcine kidney for end-stage kidney disease
Blog
Feb 10, 2025, 18:17
New 2025-2027 committee nominations are now open - IASLC
Blog
Feb 10, 2025, 18:10
Rasu Shrestha: Proud of what we, as a team across Advocate Health, have already accomplished
Blog
Feb 10, 2025, 17:17
Nelson Dusetti on personalized chemotherapy for pancreatic cancer at Jeudi du PSCC
Blog
Feb 10, 2025, 16:55
Did you know that some cancer treatments cause cardiotoxicity? - Oncogene Cancer Research
Blog
Feb 10, 2025, 16:49
AAMC Statement on Drastic Cuts to NIH-Funded Research
Science
Feb 10, 2025, 16:45
Patrick Hwu: The potential of personalized cancer vaccines as an effective adjuvant therapy in RCC
Insight
Feb 10, 2025, 16:08
Drew Moghanaki: A common-sense interpretation of clinical trial data
Blog
Feb 10, 2025, 15:56
Herbert Loong: Join us for the inaugural ESMO TAT Asia 2025 meeting
Blog
Feb 10, 2025, 15:44
Monica Bertagnolli: At times of systemic stress, it is the next generations who stand to lose the most